ADAR1 Capital Management »

Fractyl Health shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Fractyl Health (GUTS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Fractyl Health

Tip: Access up to 7 years of quarterly data

All positions including Fractyl Health held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fractyl Health by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 13k 1.59

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Fractyl Health

Nantahala Capital Management
Silverarc Capital Management
Alyeska Investment Group
Woodline Partners
Catalio Capital Management
Rosalind Advisors
General Catalyst Group Management
Deer Management
HCC Manager
683 Capital Management
Maverick Capital
Soleus Capital Management
Point72 Asset Management
Vanguard Group
M28 Capital Management

View all funds holding Fractyl Health